John J. Digiovanni

Family Medicine

56 Thomas Johnson Dr
Frederick, MD 21702

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 97 publications

A Combination of Xanthohumol and Ursolic Acid in the Diet Leads to Synergistic Inhibition of Prostate Cancer Progression.

A Combination of Xanthohumol and Ursolic Acid in the Diet Leads to Synergistic Inhibition of Prostate Cancer Progression.

Journal: Molecular carcinogenesis

Published: November 26, 2025

Uncoupling protein 3 regulates energy and stress-related pathways in undifferentiated skeletal muscle myoblasts.

Uncoupling protein 3 regulates energy and stress-related pathways in undifferentiated skeletal muscle myoblasts.

Journal: American journal of physiology. Cell physiology

Published: August 25, 2025

Synergistic Inhibition of Prostate Cancer Progression in Mice With a Combination of Curcumin and Ursolic Acid in the Diet.

Synergistic Inhibition of Prostate Cancer Progression in Mice With a Combination of Curcumin and Ursolic Acid in the Diet.

Journal: Molecular carcinogenesis

Published: April 17, 2025

GLP-1 Agonist Use Among Men With Localized Prostate Cancer: A Narrative Review and Rationale for Prospective Clinical Trials.

GLP-1 Agonist Use Among Men With Localized Prostate Cancer: A Narrative Review and Rationale for Prospective Clinical Trials.

Journal: Urology

Published: March 11, 2025

Current Efficacy and Safety and Survival Outcomes of Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.

Current Efficacy and Safety and Survival Outcomes of Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.

Journal: The Journal of investigative dermatology

Published: January 08, 2025

Corrigendum to "EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activity" [Journal of Controlled Release, 157 (2012), 287-296].

Corrigendum to "EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activity" [Journal of Controlled Release, 157 (2012), 287-296].

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: December 25, 2024

FGFR2 in the Development and Progression of Cutaneous Squamous Cell Cancer.

FGFR2 in the Development and Progression of Cutaneous Squamous Cell Cancer.

Journal: Molecular carcinogenesis

Published: October 04, 2024

Long-Term Latency of Highly Mutated Cells in Normal Mouse Skin Is Reversed by Exposure to Tumor Promoters and Chronic Tissue Damage.

Long-Term Latency of Highly Mutated Cells in Normal Mouse Skin Is Reversed by Exposure to Tumor Promoters and Chronic Tissue Damage.

Journal: Cancer discovery

Published: September 26, 2024

Obesity, dietary interventions and microbiome alterations in the development and progression of prostate cancer.

Obesity, dietary interventions and microbiome alterations in the development and progression of prostate cancer.

Journal: Frontiers in immunology

Published: June 12, 2024

Impact of Weight Management on Obesity-Driven Biomarkers of Prostate Cancer Progression.

Impact of Weight Management on Obesity-Driven Biomarkers of Prostate Cancer Progression.

Journal: The Journal of urology

Published: February 01, 2024

Novel two-tiered screening approach identifies synergistic combinations of natural compounds for prostate cancer prevention and treatment.

Novel two-tiered screening approach identifies synergistic combinations of natural compounds for prostate cancer prevention and treatment.

Journal: Molecular carcinogenesis

Published: December 07, 2023

Human mitochondrial uncoupling protein 3 functions as a metabolite transporter.

Human mitochondrial uncoupling protein 3 functions as a metabolite transporter.

Journal: FEBS letters

Published: November 05, 2023

Showing 1-12 of 97

Last Updated: 09/26/2026